| Symbol |
Name |
|
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACAP1
|
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1
|
|
ADA
|
adenosine deaminase
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADRA2A
|
adrenoceptor alpha 2A
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ANGPT2
|
angiopoietin 2
|
|
APOE
|
apolipoprotein E
|
|
ASMT
|
acetylserotonin O-methyltransferase
|
|
BAALC
|
brain and acute leukemia, cytoplasmic
|
|
BAG1
|
BCL2-associated athanogene
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCR
|
breakpoint cluster region
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BIRC7
|
baculoviral IAP repeat containing 7
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
C4B
|
complement component 4B (Chido blood group)
|
|
CALCA
|
calcitonin-related polypeptide alpha
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CD2
|
CD2 molecule
|
|
CD274
|
CD274 molecule
|
|
CD34
|
CD34 molecule
|
|
CD40LG
|
CD40 ligand
|
|
CD46
|
CD46 molecule, complement regulatory protein
|
|
CD58
|
CD58 molecule
|
|
CD59
|
CD59 molecule, complement regulatory protein
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDX2
|
caudal type homeobox 2
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CHI3L1
|
chitinase 3-like 1 (cartilage glycoprotein-39)
|
|
COMT
|
catechol-O-methyltransferase
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL13
|
chemokine (C-X-C motif) ligand 13
|
|
CXCL9
|
chemokine (C-X-C motif) ligand 9
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
|
EGFR
|
epidermal growth factor receptor
|
|
ENPP3
|
ectonucleotide pyrophosphatase/phosphodiesterase 3
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ESR1
|
estrogen receptor 1
|
|
FAAH
|
fatty acid amide hydrolase
|
|
FCN1
|
ficolin (collagen/fibrinogen domain containing) 1
|
|
FKBP5
|
FK506 binding protein 5
|
|
FLG
|
filaggrin
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FOXP3
|
forkhead box P3
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GATA2
|
GATA binding protein 2
|
|
GH1
|
growth hormone 1
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GNAS
|
GNAS complex locus
|
|
GRIK4
|
glutamate receptor, ionotropic, kainate 4
|
|
GSTO2
|
glutathione S-transferase omega 2
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
HAVCR1
|
hepatitis A virus cellular receptor 1
|
|
HAVCR2
|
hepatitis A virus cellular receptor 2
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMGB1
|
high mobility group box 1
|
|
HMOX1
|
heme oxygenase 1
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HOGA1
|
4-hydroxy-2-oxoglutarate aldolase 1
|
|
HOXA9
|
homeobox A9
|
|
HOXB4
|
homeobox B4
|
|
HPX
|
hemopexin
|
|
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ID4
|
inhibitor of DNA binding 4, dominant negative helix-loop-helix protein
|
|
IFNG
|
interferon, gamma
|
|
IL10
|
interleukin 10
|
|
IL12A
|
interleukin 12A
|
|
IL17A
|
interleukin 17A
|
|
IL18
|
interleukin 18
|
|
IL18R1
|
interleukin 18 receptor 1
|
|
IL1B
|
interleukin 1, beta
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL6
|
interleukin 6
|
|
IL7
|
interleukin 7
|
|
INS
|
insulin
|
|
JAK1
|
Janus kinase 1
|
|
JAK2
|
Janus kinase 2
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KMT2E
|
lysine (K)-specific methyltransferase 2E
|
|
LCN2
|
lipocalin 2
|
|
LEP
|
leptin
|
|
LMO2
|
LIM domain only 2 (rhombotin-like 1)
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MIR181B1
|
microRNA 181b-1
|
|
MIR181B2
|
microRNA 181b-2
|
|
MIR20A
|
microRNA 20a
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MVP
|
major vault protein
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NOTCH1
|
notch 1
|
|
NPHS1
|
nephrosis 1, congenital, Finnish type (nephrin)
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPY
|
neuropeptide Y
|
|
NUCB2
|
nucleobindin 2
|
|
OVGP1
|
oviductal glycoprotein 1, 120kDa
|
|
OXTR
|
oxytocin receptor
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
PARK7
|
parkinson protein 7
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PF4
|
platelet factor 4
|
|
PIM2
|
Pim-2 proto-oncogene, serine/threonine kinase
|
|
PKM
|
pyruvate kinase, muscle
|
|
PML
|
promyelocytic leukemia
|
|
PON1
|
paraoxonase 1
|
|
POU2AF1
|
POU class 2 associating factor 1
|
|
POU2F1
|
POU class 2 homeobox 1
|
|
PSMA2
|
proteasome (prosome, macropain) subunit, alpha type, 2
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RASGRP1
|
RAS guanyl releasing protein 1 (calcium and DAG-regulated)
|
|
REN
|
renin
|
|
RNF128
|
ring finger protein 128, E3 ubiquitin protein ligase
|
|
S100A9
|
S100 calcium binding protein A9
|
|
SCN9A
|
sodium channel, voltage gated, type IX alpha subunit
|
|
SLC18A2
|
solute carrier family 18 (vesicular monoamine transporter), member 2
|
|
SLC25A4
|
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SMAD7
|
SMAD family member 7
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
TAC1
|
tachykinin, precursor 1
|
|
TCL1A
|
T-cell leukemia/lymphoma 1A
|
|
TERC
|
telomerase RNA component
|
|
TERT
|
telomerase reverse transcriptase
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
|
TFRC
|
transferrin receptor
|
|
TG
|
thyroglobulin
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TLR9
|
toll-like receptor 9
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
|
TNFRSF6B
|
tumor necrosis factor receptor superfamily, member 6b, decoy
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TP53
|
tumor protein p53
|
|
TPH1
|
tryptophan hydroxylase 1
|
|
TRIP12
|
thyroid hormone receptor interactor 12
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
VWF
|
von Willebrand factor
|
|
WT1
|
Wilms tumor 1
|
